相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bifidobacterium bifidum NCC 453 Promotes Tolerance Induction in Murine Models of Sublingual Immunotherapy
Helene Moussu et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
Juliana De Souza Reboucas et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Adjuvants and Vector Systems for Allergy Vaccines
Philippe Moingeon et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2011)
Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study
Oliver Pfaar et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy
Stefan Schuelke et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Mechanisms of allergen-specific immunotherapy
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice
L. Mascarell et al.
MUCOSAL IMMUNOLOGY (2011)
Lactic acid bacteria as adjuvants for sublingual allergy vaccines
Laurence Van Overtvelt et al.
VACCINE (2010)
Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy
Sissela Broos et al.
VACCINE (2010)
Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction
N. Saint-Lu et al.
ALLERGY (2009)
Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009
ALLERGY (2009)
The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children
P. Majak et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
G. Senti et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy
Reto Crameri et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Natural Self-Assembly of Allergen-S-Layer Fusion Proteins Is No Prerequisite for Reduced Allergenicity and T Cell Stimulatory Capacity
Marianne Gerstmayr et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
Nicole Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A Combination Vaccine for Allergy and Rhinovirus Infections Based on Rhinovirus-Derived Surface Protein VP1 and a Nonallergenic Peptide of the Major Timothy Grass Pollen Allergen Phl p 1
Johanna Edlmayr et al.
JOURNAL OF IMMUNOLOGY (2009)
Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials
Harissios Vliagoftis et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells
Laurent Mascarell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells
Jean-Pierre Allam et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
1α,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma:: Role for IL-10 and TGF-β
Yousef A. Taher et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-10-inducing Adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model
Laurence Van Overtvelt et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route
Laurent Mascarell et al.
VACCINE (2007)
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation
Alain Razafindratsita et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders
M. Goldman
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Recombinant allergens for immunotherapy
Rudolf Valenta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Allergen immunotherapy: A practice parameter second update
Linda Cox et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Proteases as Th2 adjuvants
Martin D. Chapman et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2007)
Novel vaccines and adjuvants for allergen-specific immunotherapy
Reto Crameri et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
Peter S. Creticos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Novel ways for immune intervention in immunotherapy: Mucosal allergy vaccines
Laurent Mascarell et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Immune mechanisms of allergen-specific sublingual immunotherapy
P Moingeon et al.
ALLERGY (2006)
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy
P Johansen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses
CM Trujillo-Vargas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells
M Patel et al.
JOURNAL OF IMMUNOLOGY (2005)
ISCOM™-based vaccines:: The second decade
MT Sanders et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy
C Arikan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model
I Schöll et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells
LK Wilcock et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines
M Vajdy et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Molecular mechanisms in allergy and clinical immunology
SJ Till et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization
N Haicheur et al.
INTERNATIONAL IMMUNOLOGY (2003)
Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides
CA Akdis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies
N Mothes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy
JN Francis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Probiotics and prevention of atopic disease:: 4-year follow-up of a randomised placebo-controlled trial
M Kalliomäki et al.
LANCET (2003)
Endotoxin content of standardized allergen vaccines
L Trivedi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Mucosal immunization with DNA vaccines
P Hobson et al.
METHODS (2003)
The adenylate cyclase of Bordetella pertussis:: a vector to target antigen presenting cells
ME El Idrissi et al.
TOXICON (2002)
Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation
C Zuany-Amorim et al.
JOURNAL OF IMMUNOLOGY (2002)
Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma
JV Santeliz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Allergic rhinitis and its impact on asthma
J Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein a derived from Klebsiella pneumoniae
LN Goetsch et al.
INFECTION AND IMMUNITY (2001)
Immunostimulating complexes (ISCOMs) for nasal vaccination
KF Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
KJ Drachenberg et al.
ALLERGY (2001)
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
M Pizza et al.
VACCINE (2001)
OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway
P Jeannin et al.
NATURE IMMUNOLOGY (2000)
分享论文
